Miriam Koopman

16.3k total citations · 5 hit papers
222 papers, 8.0k citations indexed

About

Miriam Koopman is a scholar working on Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Miriam Koopman has authored 222 papers receiving a total of 8.0k indexed citations (citations by other indexed papers that have themselves been cited), including 174 papers in Oncology, 71 papers in Pathology and Forensic Medicine and 58 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Miriam Koopman's work include Colorectal Cancer Treatments and Studies (129 papers), Genetic factors in colorectal cancer (69 papers) and Gastric Cancer Management and Outcomes (42 papers). Miriam Koopman is often cited by papers focused on Colorectal Cancer Treatments and Studies (129 papers), Genetic factors in colorectal cancer (69 papers) and Gastric Cancer Management and Outcomes (42 papers). Miriam Koopman collaborates with scholars based in Netherlands, United States and Germany. Miriam Koopman's co-authors include Cornelis J.A. Punt, Linda Mol, Louis Vermeulen, Ninja Antonini, J. Han van Krieken, Irıs D. Nagtegaal, Johannes H.W. de Wilt, Frans Erdkamp, Sabine Venderbosch and C. J. Rodenburg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nature Communications.

In The Last Decade

Miriam Koopman

212 papers receiving 7.9k citations

Hit Papers

Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Co... 2009 2026 2014 2020 2009 2014 2016 2016 2015 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Chemotherapy, Bevacizumab, and Cetuximab in Metastatic Colorectal Cancer
    2009 1.0k citations Miriam Koopman, M. Elisa Vink-Börger et al. profile →
  2. Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies
    2014 534 citations Sabine Venderbosch, Irıs D. Nagtegaal et al. Clinical Cancer Research profile →
  3. From tumour heterogeneity to advances in precision treatment of colorectal cancer
    2016 439 citations Cornelis J.A. Punt, Miriam Koopman et al. profile →
  4. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database
    2016 434 citations Tim Maughan, Michel Seymour et al. profile →
  5. Nationwide trends in incidence, treatment and survival of colorectal cancer patients with synchronous metastases
    2015 364 citations Miriam Koopman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Miriam Koopman Netherlands 41 5.7k 2.0k 1.9k 1.8k 1.4k 222 8.0k
Tim Maughan United Kingdom 43 5.0k 0.9× 1.4k 0.7× 2.5k 1.3× 2.4k 1.3× 761 0.6× 243 7.7k
Christophe Tournigand France 42 7.0k 1.2× 1.2k 0.6× 3.0k 1.6× 2.4k 1.3× 2.0k 1.5× 256 9.5k
Eduardo Díaz‐Rubio Spain 49 8.7k 1.5× 1.9k 0.9× 3.5k 1.8× 2.4k 1.3× 2.0k 1.5× 351 12.0k
Per Pfeiffer Denmark 45 3.9k 0.7× 800 0.4× 1.8k 0.9× 1.9k 1.0× 639 0.5× 302 6.3k
David Malka France 57 5.5k 1.0× 916 0.5× 2.6k 1.3× 4.1k 2.3× 1.7k 1.2× 233 9.3k
Chris J. O’Callaghan Canada 32 6.3k 1.1× 1.9k 0.9× 2.9k 1.5× 1.7k 0.9× 1.2k 0.8× 106 9.1k
Enrico Cortesi Italy 41 4.7k 0.8× 783 0.4× 2.5k 1.3× 1.4k 0.8× 1.2k 0.9× 266 7.2k
Jim Cassidy United Kingdom 42 9.4k 1.7× 1.5k 0.7× 3.1k 1.6× 2.3k 1.3× 2.4k 1.7× 122 11.7k
Niall C. Tebbutt Australia 48 9.3k 1.6× 2.6k 1.3× 4.4k 2.3× 3.0k 1.7× 1.7k 1.2× 255 12.8k
Thomas H. Cartwright United States 25 7.3k 1.3× 1.1k 0.6× 3.0k 1.6× 1.5k 0.8× 2.0k 1.4× 81 11.2k

Countries citing papers authored by Miriam Koopman

Since Specialization
Citations

This map shows the geographic impact of Miriam Koopman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Miriam Koopman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Miriam Koopman more than expected).

Fields of papers citing papers by Miriam Koopman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Miriam Koopman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Miriam Koopman. The network helps show where Miriam Koopman may publish in the future.

Co-authorship network of co-authors of Miriam Koopman

This figure shows the co-authorship network connecting the top 25 collaborators of Miriam Koopman. A scholar is included among the top collaborators of Miriam Koopman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Miriam Koopman. Miriam Koopman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kruijsdijk, Rob C.M. van, Valentina Angerilli, Marije C. Baas, et al.. (2025). Risk of deficient mismatch repair colorectal cancer and precursors after kidney transplantation: A nationwide study. American Journal of Transplantation. 26(3). 480–488.
2.
Greuter, Marjolein J.E., Geraldine R. Vink, Jillian Phallen, et al.. (2024). Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer. Therapeutic Advances in Medical Oncology. 16. 12710900–12710900. 11 indexed citations
3.
Koopman, Miriam, et al.. (2024). NanoCMSer : a consensus molecular subtype stratification tool for fresh‐frozen and paraffin‐embedded colorectal cancer samples. Molecular Oncology. 19(5). 1332–1346. 1 indexed citations
4.
Bond, Marinde J. G., Maarten van Smeden, Koen Degeling, et al.. (2024). Predicting Benefit From FOLFOXIRI Plus Bevacizumab in Patients With Metastatic Colorectal Cancer. JCO Clinical Cancer Informatics. 8(8). e2400037–e2400037. 2 indexed citations
5.
Oerlemans, Simone, Nicole P. M. Ezendam, Marissa C. van Maaren, et al.. (2024). Development of a prediction model for clinically-relevant fatigue: a multi-cancer approach. Quality of Life Research. 34(1). 231–245. 1 indexed citations
6.
Goldschmeding, Roel, et al.. (2023). Spontaneous Complete Regression of Colon Cancer Liver Metastases in a Lung Transplant Patient: A Case Report. SHILAP Revista de lepidopterología. 2023. 1–7. 1 indexed citations
7.
Baan, Frederieke H. van der, Romain Cohen, Thomas Aparicio, et al.. (2023). Prognostic value of Lynch syndrome, BRAFV600E, and RAS mutational status in dMMR/MSI‐H metastatic colorectal cancer in a pooled analysis of Dutch and French cohorts. Cancer Medicine. 12(15). 15841–15853. 7 indexed citations
8.
Koopman, Miriam, et al.. (2023). Overall survival of patients with BRAF-mutant metastatic colorectal cancer treated with encorafenib-cetuximab in a real-world nationwide study in the Netherlands.. Journal of Clinical Oncology. 41(16_suppl). 3589–3589. 1 indexed citations
9.
Rooijen, Karlijn L. van, et al.. (2022). Cell-Free Circulating (Tumor) DNA before Surgery as a Prognostic Factor in Non-Metastatic Colorectal Cancer: A Systematic Review. Cancers. 14(9). 2218–2218. 21 indexed citations
10.
11.
Hoorn, Sanne ten, Linda Mol, Dirkje W. Sommeijer, et al.. (2022). Long-term Survival Update and Extended RAS Mutational Analysis of the CAIRO2 Trial: Addition of Cetuximab to CAPOX/Bevacizumab in Metastatic Colorectal Cancer. Clinical Colorectal Cancer. 22(1). 67–75. 4 indexed citations
12.
Karlsson, Mats O., et al.. (2020). Comparing Circulating Tumor Cell Counts with Dynamic Tumor Size Changes as Predictor of Overall Survival: A Quantitative Modeling Framework. Clinical Cancer Research. 26(18). 4892–4900. 10 indexed citations
13.
Kurk, Sophie A., Rebecca K. Stellato, Petra H.M. Peeters, et al.. (2019). Trajectory of body mass and skeletal muscle indices and disease progression in metastatic colorectal cancer patients. American Journal of Clinical Nutrition. 110(6). 1395–1403. 14 indexed citations
14.
Degeling, Koen, et al.. (2018). Comparing Strategies for Modeling Competing Risks in Discrete-Event Simulations: A Simulation Study and Illustration in Colorectal Cancer. Medical Decision Making. 39(1). 57–73. 15 indexed citations
15.
Vos‐Geelen, Judith de, et al.. (2017). Implementation, participation and satisfaction rates of a web-based decision support tool for patients with metastatic colorectal cancer. Annals of Oncology. 28. v201–v202. 1 indexed citations
16.
Trinh, Anne, Kari Trumpi, Felipe de Sousa e Melo, et al.. (2016). Practical and Robust Identification of Molecular Subtypes in Colorectal Cancer by Immunohistochemistry. Clinical Cancer Research. 23(2). 387–398. 132 indexed citations
17.
Bosch, Linda J.W., Yanxin Luo, Victoria Valinluck Lao, et al.. (2016). WRN Promoter CpG Island Hypermethylation Does Not Predict More Favorable Outcomes for Patients with Metastatic Colorectal Cancer Treated with Irinotecan-Based Therapy. Clinical Cancer Research. 22(18). 4612–4622. 6 indexed citations
18.
Venderbosch, Sabine, Irıs D. Nagtegaal, Tim Maughan, et al.. (2014). Mismatch Repair Status and BRAF Mutation Status in Metastatic Colorectal Cancer Patients: A Pooled Analysis of the CAIRO, CAIRO2, COIN, and FOCUS Studies. Clinical Cancer Research. 20(20). 5322–5330. 534 indexed citations breakdown →
19.
Mekenkamp, Leonie J., Josien Haan, Miriam Koopman, et al.. (2012). Chromosome 20p11 gains are associated with liver-specific metastasis in patients with colorectal cancer. Gut. 62(1). 94–101. 16 indexed citations
20.
Soetekouw, Patricia M.M.B., Miriam Koopman, David M. Burger, Vivianne C. G. Tjan‐Heijnen, & P.H.M. de Mulder. (2008). Severe hyponatremia caused by hyperglycaemia due to interferon alpha therapy in advanced renal cell carcinoma. Acta Oncologica. 48(1). 154–156. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tim Maughan Breakdown of academic impact, for papers by Christophe Tournigand Breakdown of academic impact, for papers by Eduardo Díaz‐Rubio Breakdown of academic impact, for papers by Per Pfeiffer Breakdown of academic impact, for papers by David Malka Breakdown of academic impact, for papers by Chris J. O’Callaghan Breakdown of academic impact, for papers by Enrico Cortesi Breakdown of academic impact, for papers by Jim Cassidy Breakdown of academic impact, for papers by Niall C. Tebbutt Breakdown of academic impact, for papers by Thomas H. Cartwright
Rankless by CCL
2026